Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd.
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is...
advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 08, 2022 11:30am
Enjoy the long weekend ! Checkout these stocks, do UR DD !
$EMO - TSX $BOMO - OTC $TONR - OTC $BYOC - OTC $ETEK - OTC GLTA !!!
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 07, 2022 8:50pm
Hate W/Ends & Holidays until I become Rich $$$$$$ !
#Bucillamine
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Oct 06, 2022 12:34pm
THIS NEWS REPORT LOOKS GOOD!!
Waiting for two years, Whats two more weeks!? Awesome.. Better late than never
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 06, 2022 10:52am
$RVV $RVVTF - Update !
#Bucillamine https://ca.finance.yahoo.com/news/revive-therapeutics-provides-phase-3-141800196.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 06, 2022 10:18am
New Press Release - Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced an update on...
read article.
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Oct 04, 2022 9:47am
RE:This should be a good day for RVV
Hahaha, with tears...
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Post by
TheTerminator1
on Oct 04, 2022 7:51am
This should be a good day for RVV
Fingers crossed
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Post by
TheTerminator1
on Oct 03, 2022 9:17am
A $0.40 bid would be even better
While you are at it!
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Post by
TheTerminator1
on Oct 03, 2022 9:00am
RVV pumpers and bashers are the same people!
Get a life people!
(12)
•••
DehydraTECH
X
View Profile
View Bullboard History
Post by
DehydraTECH
on Sep 30, 2022 8:24am
you want an easy 10x
follow $STSS ULTRALOW waste syringes with production starting this quarter only 9 million cap raised 24 milllion pre money and new IPO THIS YEAR ..gift
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Sep 29, 2022 8:04pm
Revive Hits a Snag? That didn’t happen folks ! $$$$$$$ !!
#Bucillamine https://internetstockreview.com/revive-hits-a-snag/
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Sep 29, 2022 7:48am
Revive Therapeutics To Schedule DSMB Meeting In Lieu Of FDA
#Bucillamine https://thedalesreport.com/psychedelics/revive-therapeutics-to-forge-ahead-with-dsmb-meeting-despite-fda-decision/
(163)
•••
MyAli4s
X
View Profile
View Bullboard History
Comment by
MyAli4s
on Sep 29, 2022 7:07am
RE:It's going to get real,,,, real fast
If bucillamine had any effect on covid it would be known already!
(11)
•••
Batemanwanabe
X
View Profile
View Bullboard History
Post by
Batemanwanabe
on Sep 29, 2022 4:35am
It's going to get real,,,, real fast
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170062599
(5)
•••
1ottrunner
X
View Profile
View Bullboard History
Comment by
1ottrunner
on Sep 28, 2022 9:59am
RE:Probably means one hell of a buying
Some people will dig through a turd for days looking for a diamond and end up with a peanut.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study